PJ Mease, A Lertratanakul, JK Anderson… - Annals of the …, 2021 - ard.bmj.com
Background Upadacitinib is a Janus kinase inhibitor under evaluation for the treatment of
psoriatic arthritis (PsA). We evaluated upadacitinib in patients with PsA and prior inadequate …